The Dana-Farber Cancer Institute has received a $5 million gift from the Edward P. Evans Foundation in support of research on myelodysplastic syndromes (MDS).
What is MDS?
A group of bone marrow disorders that impact the body’s ability to generate sufficient amounts of healthy red blood cells, about 20% of those suffering from MDS will develop acute myeloid leukemia (AML).
The Only Cure to Date
Thus far the only known cure for MDS is a bone marrow transplant from a healthy donor—but fewer than 10% of those afflicted by the disease can undergo a transplant due to advanced age or a specific medical problem reports Philanthropy News Digest.
The Edwards P. Evans Center for Myelodysplastic Syndromes at Dana-Farber
The funds from the Newton-based foundation will now establish The Edwards P. Evans Center for Myelodysplastic Syndromes at Dana-Farber which capitalizes on the fact that the clinical research center has a longstanding track record conducting MDS-related research.
The Edward P. Evans Foundation Comment
“Since 2011, the Edward P. Evans Foundation has contributed more than $66 million to medical research directed at improving outcomes and finding a cure for MDS patients” ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).